Pediatric-type diffuse high-grade glioma, H3- and IDH-wildtype

What it is

Pediatric-type diffuse high-grade glioma, H3-wildtype and IDH-wildtype is an aggressive childhood glioma that lacks both H3 mutations (which define diffuse midline and hemispheric gliomas) and IDH mutations (seen in adult gliomas). It is defined instead by other molecular features and is a serious tumor.

Understanding Pediatric-type diffuse high-grade glioma, H3- and IDH-wildtype

This category captures pediatric high-grade gliomas that do not fit the H3-mutant or IDH-mutant groups. They are defined by other molecular alterations (which can include changes in various genes and pathways), identified through molecular testing. As aggressive tumors, they are managed with multimodal treatment — surgery, radiation, and chemotherapy — and are serious diagnoses. Because their biology varies, identifying the specific molecular features can be important for prognosis and for considering targeted treatments or clinical trials. Care is typically pursued at specialized pediatric centers. Recognizing this distinct category ensures these tumors are appropriately diagnosed and not confused with the H3- or IDH-mutant types. Understanding this glioma clarifies an aggressive childhood tumor defined by molecular features other than H3 or IDH.

Why it matters

Understanding this glioma helps families see that some aggressive childhood gliomas lack the H3 and IDH mutations and are defined by other molecular features — making molecular testing important for diagnosis, prognosis, and treatment options.